Only available ultra–low-dose OC with just 10 mcg of daily ethinyl estradiol in a 24/2/2 regimen for short, lighter periods1,2,*,†
Low-dose, 20 mcg-option with 24/4 dosing for cycle control and less bleeding by Cycle 62,7,‡,**
To receive your samples of Lo Loestrin Fe and Minastrin 24 Fe, click the “order samples” button.
Please print out the form provided and fax the completed form to 1-877-801-9949.
Lo Loestrin Fe or Minastrin 24 Fe are contraindicated in pregnant patients, and those with a high risk of arterial or venous thrombotic diseases, liver tumors (benign or malignant) or liver disease, undiagnosed abnormal uterine bleeding, or breast cancer or other estrogen- or progestin-sensitive cancer, now or in the past.
Warnings and Precautions
Discontinue Lo Loestrin Fe or Minastrin 24 Fe if a thrombotic event occurs, and at least 4 weeks before and through 2 weeks after major surgery. Lo Loestrin Fe or Minastrin 24 Fe should not be started any earlier than 4 weeks after delivery, in women who are not breastfeeding. If jaundice occurs, treatment should be discontinued.
Lo Loestrin Fe or Minastrin 24 Fe should not be prescribed for women with uncontrolled hypertension or hypertension with vascular disease. Women who are pre-diabetic or diabetic, should be monitored while using Lo Loestrin Fe or Minastrin 24 Fe. Alternate contraceptive methods should be considered for women with uncontrolled dyslipidemia. Patients using Lo Loestrin Fe or Minastrin 24 Fe who have a significant change in headaches or irregular bleeding or amenorrhea should be evaluated.
In the clinical trial for Lo Loestrin Fe, the most common adverse reactions (incidence ≥2%) were nausea/vomiting, headache, bleeding irregularities, dysmenorrhea, weight fluctuation, breast tenderness, acne, abdominal pain, anxiety, and depression.
In the clinical trial for Minastrin 24 Fe, the most common adverse reactions (incidence ≥2%) were headache, vaginal candidiasis, nausea, menstrual cramps, breast tenderness, bacterial vaginitis, abnormal cervical smear, acne, mood swings, and weight gain.
Lo Loestrin Fe or Minastrin 24 Fe will not protect against HIV infection (AIDS) or other sexually transmitted diseases.
To report a Suspected Adverse Reaction from one of our products, please contact Actavis Drug Safety Department at 1-800-272-5525.